Retraction Note: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases (Nature, (2009), 457, 7232, (981-989), 10.1038/nature07767);APP binds DR6 to trigger axon pruning and neuron death via distinct caspases

Nature

Volumn 457, Issue 7232, 2009, Pages 981-989

  Nikolaev, Anatoly ^a   McLaughlin, Todd ^b   O'Leary, Dennis D M ^b   Tessier Lavigne, Marc ^a  

^a GENENTECH INC   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; CASPASE; DEATH RECEPTOR; DEATH RECEPTOR 6; UNCLASSIFIED DRUG;

APOPTOSIS; LIGAND; MORTALITY; MUTATION; NERVOUS SYSTEM; NERVOUS SYSTEM DISORDER; PROTEIN; RODENT;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; LIGAND BINDING; MOUSE; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVE FIBER; NEUROMUSCULAR SYNAPSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

MUS;

EID: 60549089207     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/s41586-023-06943-3     Document Type: Erratum

References (59)

1. Raff, M. C., Whitmore, A. V. & Finn, J. T. Axonal self-destruction and neurodegeneration. Science 296, 868-871 (2002).
2. Luo, L. & O'Leary, D. D. Axon retraction and degeneration in development and disease. Annu. Rev. Neurosci. 28, 127-156 (2005).
3. Buss, R. R., Sun, W. & Oppenheim, R. W. Adaptive roles of programmed cell death during nervous system development. Annu. Rev. Neurosci. 29, 1-35 (2006).
4. Saxena, S. & Caroni, P. Mechanisms of axon degeneration: from development to disease. Prog. Neurobiol. 83, 174-191 (2007).
5. Haase, G., Pettmann, B., Raoul, C. & Henderson, C. E. Signaling by death receptors in the nervous system. Curr. Opin. Neurobiol. 18, 284-291 (2008).
6. Kuida, K. et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384, 368-372 (1996).
7. White, F. A., Keller-Peck, C. R., Knudson, C. M., Korsmeyer, S. J. & Snider, W. D. Widespread elimination of naturally occurring neuronal death in Bax-deficient mice. J. Neurosci. 18, 1428-1439 (1998).
8. Finn, J. T. et al. Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J. Neurosci. 20, 1333-1341 (2000).
9. Kuo, C. T., Zhu, S., Younger, S., Jan, L. Y. & Jan, Y. N. Identification of E2/E3 ubiquitinating enzymes and caspase activity regulating Drosophila sensory neuron dendrite pruning. Neuron 51, 283-290 (2006).
10. Williams, D. W., Kondo, S., Krzyzanowska, A., Hiromi, Y. & Truman, J. W. Local caspase activity directs engulfment of dendrites during pruning. Nature Neurosci. 9, 1234-1236 (2006).
11. Plachta, N. et al. Identification of a lectin causing the degeneration of neuronal processes using engineered embryonic stem cells. Nature Neurosci. 10, 712-719 (2007).
12. Sagot, Y. et al. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J. Neurosci. 15, 7727-7733 (1995).
13. Watts, R. J., Hoopfer, E. D. & Luo, L. Axon pruning during Drosophila metamorphosis: evidence for local degeneration and requirement of the ubiquitin-proteasome system. Neuron 38, 871-885 (2003).
14. Bodmer, J. L., Schneider, P. & Tschopp, J. The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 27, 19-26 (2002).
15. Bossen, C. et al. Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. J. Biol. Chem. 281, 13964-13971 (2006).
16. Pan, G. et al. Identification and functional characterization of DR6, a novel death domain-containing TNF receptor. FEBS Lett. 431, 351-356 (1998).
17. Zhao, H. et al. Impaired c-Jun amino terminal kinase activity and T cell differentiation in death receptor 6-deficient mice. J. Exp. Med. 194, 1441-1448 (2001).
18. Schmidt, C. S. et al. Enhanced B cell expansion, survival, and humoral responses by targeting death receptor 6. J. Exp. Med. 197, 51-62 (2003).
19. Walsh, D. M. et al. The APP family of proteins: similarities and differences. Biochem. Soc. Trans. 35, 416-420 (2007).
20. Reinhard, C., Hebert, S. S. & De Strooper, B. The amyloid-β precursor protein: integrating structure with biological function. EMBO J. 24, 3996-4006 (2005).
21. Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356 (2002).
22. Haass, C. & Selkoe, D. J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide. Nature Rev. Mol. Cell Biol. 8, 101-112 (2007).
23. Wang, H. & Tessier-Lavigne, M. En passant neurotrophic action of an intermediate axonal target in the developing mammalian CNS. Nature 401, 765-769 (1999).
24. Campenot, R. B., Walji, A. H. & Draker, D. D. Effects of sphingosine, staurosporine, and phorbol ester on neurites of rat sympathetic neurons growing in compartmented cultures. J. Neurosci. 11, 1126-1139 (1991).
25. Cole, S. L. & Vassar, R. BACE1 structure and function in health and Alzheimer's disease. Curr. Alzheimer Res. 5, 100-120 (2008).
26. Edwards, P. D. et al. Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency. J. Med. Chem. 50, 5912-5925 (2007).
27. Slunt, H. H. et al. Expression of a ubiquitous, cross-reactive homologue of the mouse β-amyloid precursor protein (APP). J. Biol. Chem. 269, 2637-2644 (1994).
28. Hilbich, C., Monning, U., Grund, C., Masters, C. L. & Beyreuther, K. Amyloid-like properties of peptides flanking the epitope of amyloid precursor protein-specific monoclonal antibody 22C11. J. Biol. Chem. 268, 26571-26577 (1993).
29. Wang, P. et al. Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-like protein 2. J. Neurosci. 25, 1219-1225 (2005).
30. Singh, K. K. et al. Developmental axon pruning mediated by BDNF-p75NTR-dependent axon degeneration. Nature Neurosci. 11, 649-658 (2008).
31. Deppmann, C. D. et al. A model for neuronal competition during development. Science 320, 369-373 (2008).
32. LeBlanc, A., Liu, H., Goodyer, C., Bergeron, C. & Hammond, J. Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease. J. Biol. Chem. 274, 23426-23436 (1999).
33. Horowitz, P. M. et al. Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease. J. Neurosci. 24, 7895-7902 (2004).
34. Guo, H. et al. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease. Am. J. Pathol. 165, 523-531 (2004).
35. Klaiman, G., Petzke, T. L., Hammond, J. & Leblanc, A. C. Targets of caspase-6 activity in human neurons and Alzheimer disease. Mol. Cell. Proteomics 7, 1541-1555 (2008).
36. Young-Pearse, T. L., Chen, A. C., Chang, R., Marquez, C. & Selkoe, D. J. Secreted APP regulates the function of full-length APP in neurite outgrowth through interaction with integrin β1. Neural Develop. 3, 15 (2008).
37. Heber, S. et al. Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J. Neurosci. 20, 7951-7963 (2000).
38. Perez, R. G., Zheng, H., Van der Ploeg, L. H. & Koo, E. H. The β-amyloid precursor protein of Alzheimer's disease enhances neuron viability and modulates neuronal polarity. J. Neurosci. 17, 9407-9414 (1997).
39. Han, P. et al. Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: a novel excitoprotective mechanism involving modulation of Tau phosphorylation. J. Neurosci. 25, 11542-11552 (2005).
40. Matrone, C. et al. Activation of the amyloidogenic route by NGF deprivation induces apoptotic death in PC12 cells. J. Alzheimers Dis. 13, 81-96 (2008).
41. Matrone, C., Ciotti, M. T., Mercanti, D., Marolda, R. & Calissano, P. NGF and BDNF signaling control amyloidogenic route and Aβ production in hippocampal neurons. Proc. Natl Acad. Sci. USA 105, 13139-13144 (2008).
42. Medana, I. M. & Esiri, M. M. Axonal damage: a key predictor of outcome in human CNS diseases. Brain 126, 515-530 (2003).
43. Chiang, L. W. et al. An orchestrated gene expression component of neuronal programmed cell death revealed by cDNA array analysis. Proc. Natl Acad. Sci. USA 98, 2814-2819 (2001).
44. Muller, T., Meyer, H. E., Egensperger, R. & Marcus, K. The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-relevance for Alzheimer's disease. Prog. Neurobiol. 85, 393-406 (2008).
45. Van Gool, D., De Strooper, B., Van Leuven, F. & Dom, R. Amyloid precursor protein accumulation in Lewy body dementia and Alzheimer's disease. Dementia 6, 63-68 (1995).
46. Palmert, M. R. et al. Antisera to an amino-terminal peptide detect the amyloid protein precursor of Alzheimer's disease and recognize senile plaques. Biochem. Biophys. Res. Commun. 156, 432-437 (1988).
47. Bertram, L. & Tanzi, R. E. Alzheimer's disease: one disorder, too many genes? Hum. Mol. Genet. 13, R135-R141 (2004).
48. Doyle, J. P. et al. Application of a translational profiling approach for the comparative analysis of CNS cell types. Cell 135, 749-762 (2008).
49. Albrecht, S. et al. Activation of caspase-6 in aging and mild cognitive impairment. Am. J. Pathol. 170, 1200-1209 (2007).
50. Graham, R. K. et al. Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 125, 1179-1191 (2006).
51. Sabatier, C. et al. The divergent Robo family protein rig-1/Robo3 is a negative regulator of slit responsiveness required for midline crossing by commissural axons. Cell 117, 157-169 (2004).
52. Atwal, J. K. et al. PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science 322, 967-970 (2008).
53. Chen, Z. et al. Alternative splicing of the Robo3 axon guidance Receptor governs the midline switch. Neuron 58, 325-332 (2008).
54. Higuchi, H., Yamashita, T., Yoshikawa, H. & Tohyama, M. Functional inhibition of the p75 receptor using a small interfering RNA. Biochem. Biophys. Res. Commun. 301, 804-809 (2003).
55. McLaughlin, T., Torborg, C. L., Feller, M. B. & O'Leary, D. D. Retinotopic map refinement requires spontaneous retinal waves during a brief critical period of development. Neuron 40, 1147-1160 (2003).
56. Pettmann, B. et al. Biological activities of nerve growth factor bound to nitrocellulose paper by western blotting. J. Neurosci. 8, 3624-3632 (1988).
57. Okada, A. et al. Boc is a receptor for sonic hedgehog in the guidance of commissural axons. Nature 444, 369-373 (2006).
58. Knudson, C. M. et al. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270, 96-99 (1995).
59. Lee, K. F. et al. Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell 69, 737-749 (1992).